Home » Topics » BioWorld Science

BioWorld Science
RSS

Takeda targets Helicobacter pylori

March 15, 1996

Anti-Helicobacter agents from Janssen

March 15, 1996

Synsorb develops drug for hemorrhagic colitis

March 15, 1996

VML-252 for hyperphosphatemia

March 15, 1996

Fibrinogen antagonists from E. Merck

March 15, 1996

First introduction for certoparin

March 15, 1996

Class III antiarrhythmics from Mitsui Toatsu

March 15, 1996

Kirin to codevelop antiischemic drug candidate

March 15, 1996

Potassium channel openers from Nippon Kayaku

March 15, 1996

Ciba-Geigy claims renin inhibitors

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...